0000899243-16-020912.txt : 20160525 0000899243-16-020912.hdr.sgml : 20160525 20160525165457 ACCESSION NUMBER: 0000899243-16-020912 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20160525 FILED AS OF DATE: 20160525 DATE AS OF CHANGE: 20160525 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REATA PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001358762 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 113651945 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2801 GATEWAY DRIVE SUITE 150 CITY: IRVING STATE: TX ZIP: 75063 BUSINESS PHONE: 972-865-2206 MAIL ADDRESS: STREET 1: 2801 GATEWAY DRIVE SUITE 150 CITY: IRVING STATE: TX ZIP: 75063 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Stone Dennis K. CENTRAL INDEX KEY: 0001662323 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37785 FILM NUMBER: 161675227 MAIL ADDRESS: STREET 1: C/O REATA PHARMACEUTICALS, INC. STREET 2: 2801 GATEWAY DR. SUITE 150 CITY: IRVING STATE: TX ZIP: 75063 3 1 doc3.xml FORM 3 SUBMISSION X0206 3 2016-05-25 0 0001358762 REATA PHARMACEUTICALS INC RETA 0001662323 Stone Dennis K. 2801 GATEWAY DRIVE, SUITE 150 IRVING TX 75063 1 0 0 0 Class B common stock Class A common stock 31803 D The Class B common stock is convertible into Class A common stock on a one-for-one basis (a) at the holder's election at any time after the date that is six months following the date of the closing of the initial public offering of the company's Class A common stock, (b) at the holder's election prior to that time subject to certain conditions, or (c) at the option of the company's board of directors, in its sole discretion, at any time or multiple times from time to time on or before the closing of the initial public offering. The conversion right of the Class B common stock has no expiration date. Exhibit List: Exhibit 24 - Power of Attorney /s/ Michael D. Wortley, attorney-in-fact 2016-05-25 EX-24 2 attachment1.htm EX-24 DOCUMENT
                                POWER OF ATTORNEY
                    FOR EXECUTING FORMS 3, FORMS 4, FORMS 5,
                       FORM 144 AND SCHEDULE 13D AND 13G

The undersigned hereby constitutes and appoints Michael D. Wortley or Anne T.
Yager, or any of them acting without the other, with full power of substitution,
as the undersigned's true and lawful attorney-in-fact to:

     1.   Execute for and on behalf of the undersigned (a) any Form 3, Form 4
          and Form 5 (including amendments thereto) in accordance with Section
          16(a) of the Securities Exchange Act of 1934, as amended (the
          "Exchange Act"), (b) Form 144 and (c) Schedule 13D and Schedule 13G
          (including amendments thereto) in accordance with Sections 13(d) and
          13(g) of the Exchange Act, but only to the extent each form or
          schedule relates to the undersigned's beneficial ownership of
          securities of Reata Pharmaceuticals, Inc.;

     2.   Do and perform any and all acts for and on behalf of the undersigned
          that may be necessary or desirable to complete and execute any Form 3,
          Form 4, Form 5, Form 144, Schedule 13D or Schedule 13G (including
          amendments thereto) and timely file the forms or schedules with the
          Securities and Exchange Commission and any stock exchange or quotation
          system, self-regulatory association or any other authority, and
          provide a copy as required by law or advisable to such persons as the
          attorney-in-fact deems appropriate; and

     3.   Take any other action in connection with the foregoing that, in the
          opinion of the attorney-in-fact, may be of benefit to, in the best
          interest of or legally required of the undersigned, it being
          understood that the documents executed by the attorney-in-fact on
          behalf of the undersigned pursuant to this Power of Attorney shall be
          in the form and shall contain the terms and conditions as the
          attorney-in-fact may approve in the attorney-in-fact's discretion.

The undersigned hereby grants to the attorney-in-fact full power and authority
to do and perform all and every act requisite, necessary or proper to be done in
the exercise of any of the rights and powers herein granted, as fully to all
intents and purposes as the undersigned might or could do if personally present,
with full power of substitution or revocation, hereby ratifying and confirming
all that the attorney-in-fact shall lawfully do or cause to be done by virtue of
this Power of Attorney and the rights and powers granted herein. The undersigned
acknowledges that the attorneys-in-fact, in serving in such capacity at the
request of the undersigned, are not assuming (nor is Reata Pharmaceuticals, Inc.
assuming) any of the undersigned's responsibilities to comply with Section 16 of
the Exchange Act.

The undersigned agrees that the attorney-in-fact may rely entirely on
information furnished orally or in writing by or at the direction of the
undersigned to the attorney-in-fact. The undersigned also agrees to indemnify
and hold harmless Reata Pharmaceuticals, Inc. and the attorney-in-fact against
any losses, claims, damages or liabilities (or actions in these respects) that
arise out of or are based upon any untrue statements or omissions of necessary
facts in the information provided by or at the direction of the undersigned, or
upon the lack of timeliness in the delivery of information by or at the
direction of the undersigned, to the attorney-in fact for purposes of executing,
acknowledging, delivering or filing a Form 3, Form 4, Form 5, Form 144, Schedule
13D or Schedule 13G (including any amendments, corrections, supplements or other
changes thereto) with respect to the undersigned's holdings of and transactions
in securities issued by Reata Pharmaceuticals, Inc., and agrees to reimburse
Reata Pharmaceuticals, Inc. and the attorney-in-fact on demand for any legal or
other expenses reasonably incurred in connection with investigating or defending
against any such loss, claim, damage, liability or action.

This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Form 3, Form 4, Form 5, Form 144,
Schedule 13D and Schedule 13G (including any amendments, corrections,
supplements or other changes thereto) with respect to the undersigned's holdings
of and transactions in securities issued by Reata Pharmaceuticals, Inc., unless
earlier revoked by the undersigned in a signed writing delivered to the
attorney-in-fact. This Power of Attorney does not revoke any other power of
attorney that the undersigned has previously granted.

IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executed as of the date written below.


/s/ Dennis K. Stone, M.D.
----------------------------------------
Signature
Dennis K. Stone, M.D.
----------------------------------------
Name
11/12/15
----------------------------------------
Date